Jefferies Analyst: Aurora Cannabis and 4 other pot stocks at purchase


Market research firm Jefferies on Monday released a cover of cannabis activity with a note from analyst Owen Bennett, who initiated the ratings of nine companies while estimating that the legitimate plant sector would reach 50 billion USD of annual sales over the next decade, up from $ 17 billion this year.

Bennett also said that a "realistic" scenario could allow the industry to generate sales of up to $ 130 billion by 2029, due to the disruptive nature of the company .

"We anticipate a core conservative industry of more than $ 50 billion by 2029 and a realistic increase of $ 130 billion resulting from a wider disruption of the industry," he said. -he writes. "The global winners will be those who lead in both the medical and recreational fields and have a strong position in the US The fears of trivialization are exaggerated." Expect further consolidation, more [mainstream consumer-goods companies] take positions and focus short-term performance against expectations of headlines / capabilities. "

Of the nine companies initiated by Bennett, he awarded the "Buy" rating at five, the "Keep" rating at two and the "Underperformance" rating at two others, as follows:

  • Aurora Cannabis Inc. (ACB). Bennett awarded ACB a "Buy" rating, with a target price of $ 12.
  • CannTrust Holdings Inc. (CNTTF). CannTrust has been awarded the "Buy" rating and a target price of C $ 15.
  • Canopy Growth Corp. (GSC). CGC received the "Pending" rating, with a price target of $ 64 CAD.
  • Cronos Group Inc. (CRON). CRON was rated underperformance and received a target price of $ 17 CAD.
  • Emerald Health Therapeutics (EMHTF). The Jefferies analyst gave Emerald a "Hold" rating, with a target price of 4.30 Canadian dollars.
  • Flowr Corp. (FLWPF). This stock received the "Buy" rating, with a target price of $ 5.70 CAD.
  • Dutch Green Bio (TGODF). The analyst ranked this stock in the "Buy" category with a target price of $ 6.10.
  • Hexo Corp. (Hexo). Bennett ranked Hexo as "Underperform", giving him a target price of $ 5.60 CAD.
  • OrganiGram Holdings Inc. (OGRMF). OGRMF evaluates a "purchase" and a price target of 10 Canadian dollars.

Source link